Protagonist Therapeutics Inc. (PTGX) Rose 6.28% or 0.4 To Price $6.77 On Thursday

Protagonist Therapeutics Inc. (PTGX) rose 6.28% or 0.4 to $6.77. It is nearly 96003 shares traded, which is 80.82% compare to the average total volume 118781. The market cap of PTGX is $163.74 million. The year to date change is -63.6%. The 52 week price range is from $5.49 to $23.97. Price of PTGX have changed 1.11% during last week. It have changed -19.67% over last month, -32.73% over last 3 months, -12.62% over last 6 months and -65.36% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for PTGX is 8.50. It is 25.55% above current price. The 200-day Moving Averages for PTGX is 9.62. It is 42.10% above current price. The 52-week High is 23.97. It is 254.06% from the current price. The 52-week Low is 5.49. It is -18.91% from current price.

There are some statistics of PTGX. It is has market cap $163.74 million. The share outstanding is 24.19 million. The average volume is 118781. The percent of top 15 Institution holding is 106.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of PTGX is -31.03%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of PTGX is -21.78%.


Share this post